Value | Category | Cases | |
---|---|---|---|
1 | Astrazeneca | 42 |
10.4%
|
2 | No sé | 153 |
37.8%
|
3 | Pfizer | 58 |
14.3%
|
4 | Sinopharm | 152 |
37.5%
|
Missing value | 5435 |